Li HN - Search Results

1

Deciphering the TCF19/miR-199a-5p/SP1/LOXL2 pathway: Implications for breast cancer metastasis and epithelial-mesenchymal transition.

Li SY, Zhang N, Zhang H, Wang N, Du YY, Li HN, Huang CS, Li XR. Li SY, et al. Among authors: li hn, li xr. Cancer Lett. 2024 Aug 10;597:216995. doi: 10.1016/j.canlet.2024.216995. Epub 2024 Jun 6. Cancer Lett. 2024. PMID: 38851313

2

Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway.

Xu T, Zhang R, Dong M, Zhang Z, Li H, Zhan C, Li X. Xu T, et al. Onco Targets Ther. 2019 Dec 4;12:10639-10650. doi: 10.2147/OTT.S222967. eCollection 2019. Onco Targets Ther. 2019. PMID: 31824171 Free PMC article.

3

ZW10 interacting kinetochore protein may serve as a prognostic biomarker for human breast cancer: An integrated bioinformatics analysis.

Li HN, Zheng WH, Du YY, Wang G, Dong ML, Yang ZF, Li XR. Li HN, et al. Among authors: li xr. Oncol Lett. 2020 Mar;19(3):2163-2174. doi: 10.3892/ol.2020.11353. Epub 2020 Jan 24. Oncol Lett. 2020. PMID: 32194714 Free PMC article.

4

Elevated mRNA expression levels of DLGAP5 are associated with poor prognosis in breast cancer.

Xu T, Dong M, Li H, Zhang R, Li X. Xu T, et al. Oncol Lett. 2020 Jun;19(6):4053-4065. doi: 10.3892/ol.2020.11533. Epub 2020 Apr 10. Oncol Lett. 2020. PMID: 32391106 Free PMC article.

5

The Association Between Foxp3 Polymorphisms and Risk of Graves' Disease: A Systematic Review and Meta-Analysis of Observational Studies.

Li HN, Li XR, Du YY, Yang ZF, Lv ZT. Li HN, et al. Among authors: li xr. Front Endocrinol (Lausanne). 2020 Jun 16;11:392. doi: 10.3389/fendo.2020.00392. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32612577 Free PMC article.

6

Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer.

Xu T, Dong M, Wang Z, Li H, Li X. Xu T, et al. Cancer Manag Res. 2020 Jul 14;12:5773-5786. doi: 10.2147/CMAR.S253349. eCollection 2020. Cancer Manag Res. 2020. PMID: 32765080 Free PMC article.

7

Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high-level immune infiltration status.

Li HN, Li XR, Lv ZT, Cai MM, Wang G, Yang ZF. Li HN, et al. Among authors: li xr. Cancer Med. 2020 Dec;9(24):9554-9570. doi: 10.1002/cam4.3543. Epub 2020 Oct 14. Cancer Med. 2020. PMID: 33058542 Free PMC article.

8

TMEM158 May Serve as a Diagnostic Biomarker for Anaplastic Thyroid Carcinoma: An Integrated Bioinformatic Analysis.

Li HN, Du YY, Xu T, Zhang R, Wang G, Lv ZT, Li XR. Li HN, et al. Among authors: li xr. Curr Med Sci. 2020 Dec;40(6):1137-1147. doi: 10.1007/s11596-020-2296-8. Epub 2021 Jan 11. Curr Med Sci. 2020. PMID: 33428142

9

MRPL13 Promotes Tumor Cell Proliferation, Migration and EMT Process in Breast Cancer Through the PI3K-AKT-mTOR Pathway.

Cai M, Li H, Chen R, Zhou X. Cai M, et al. Cancer Manag Res. 2021 Feb 25;13:2009-2024. doi: 10.2147/CMAR.S296038. eCollection 2021. Cancer Manag Res. 2021. PMID: 33658859 Free PMC article.

10

NCAPG upregulation mediated by four microRNAs combined with activation of the p53 signaling pathway is a predictor of poor prognosis in patients with breast cancer.

Dong M, Xu T, Cui X, Li H, Li X, Xia W. Dong M, et al. Oncol Lett. 2021 Apr;21(4):323. doi: 10.3892/ol.2021.12585. Epub 2021 Feb 23. Oncol Lett. 2021. PMID: 33692855 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters